CONSIDER LIGHTLY ADDING TO CANCER STOCK SHORTS ON THIS RALLY

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of ...
Read more »

STATUS OF CANCER STOCKS

Per our earlier post, we are short on OSIP from $32.2, SNTA from $3.50and EXEL from $5.35.We are long on PARD from $4.45www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO ...
Read more »

ENCOURAGING DATA AT ASCO

Our review of the data presented at 2009 Annual Meeting of the American Society of Clinical Oncology held in Orlando shows that the following stocks may move in response to the data:SNTA,ZIOP,CLDX,EXEL,BVTI,ABII,OGXI,INFI,OSIP AND PARD.If the ...
Read more »
Follow

Get every new post delivered to your Inbox

Join other followers